• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Antibiotic innovation helps fight against superbugs

Bioengineer by Bioengineer
February 7, 2023
in Health
Reading Time: 3 mins read
0
Dr Celine Valery Pipette
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs.

Dr Celine Valery Pipette

Credit: RMIT University

RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs.

Developed by PhD candidate Priscila Cardoso and principal supervisor Dr Céline Valéry from RMIT’s School of Health and Biosciences, the antibiotic has a simple design that allows it to be produced quickly and cost-effectively in a lab.

Named Priscilicidin, the antibiotic’s amino acid building blocks are small, so it can be tailored to tackle different types of antimicrobial resistance.

With the World Health Organization calling antimicrobial resistance “one of the top ten global public health threats facing humanity”, developing new antibiotics is more urgent than ever.

Professor Charlotte Conn, one of Cardoso’s PhD supervisors, said given that urgency, Priscilicidin was an exciting breakthrough for public health.

Priscilicidin is a type of antimicrobial peptide. These peptides are produced by all living organisms as the first defense against bacteria and viruses.

After reviewing the literature on antimicrobial peptide molecular engineering, the team designed and tested 20 short peptides before settling on Priscilicidin as the best candidate.

“The pharmaceutical industry generally tests thousands of compounds before getting a lead candidate. In our case, only 20 designs were necessary to create an entire new family of antibiotics,” Valéry said.

Conn said Priscilicidin was based on a natural antibiotic peptide, which made it less likely to cause antimicrobial resistance compared to existing conventional antibiotics.

“Current natural antibiotics are expensive and difficult to make on a large scale. They also break down quickly in the body,” she said

“Priscilicidin combines the advantages of small molecular design, which means it’s quick and inexpensive to synthesise in a lab, with the advantages of natural antibiotics.”

How does Priscilicidin work?

Priscilicidin was derived from Indolicidin, a natural antibiotic found in cows’ immune systems.

The team’s research, published in January 2023 in the Women in Nanoscience 2022 special issue of Frontiers in Chemistry, showed Priscilicidin was highly active against resistant microbial strains such as golden staph, E. coli bacteria and candida fungi.

Priscilicidin works by disturbing the membrane of the microbes, eventually killing the cell. “Attacking this outer layer makes it harder for the bacteria to evolve and resist treatment,” said Valéry.

Lab tests showed Priscilicidin had a similar antimicrobial activity as Indolicidin on common bacterial and fungal infections.

A new arsenal of topical and oral antibiotics

The team’s research shows Priscilicidin’s molecules naturally self-assemble into hydrogel form, making it ideal for creating antibiotic gels and creams.

Valéry said when new drugs were created, scientists needed to consider the drug’s pharmaceutical formulation.

This includes the drug’s form (capsule or cream, for example) and processes involved.

Priscilicidin’s natural hydrogel form meant they can bypass some of that formulation process, Valéry said.

“The fact we can control the viscosity of Priscilicidin means we can contemplate many applications as different products, diversifying the types of treatments to stop antimicrobial resistance,” she said.

While the team are predominantly investigating Priscilicidin for topical applications, they are not ruling out oral applications.

“In theory, you could choose all means of administration for Priscilicidin, but none of them have been tested yet,” Conn said.

“We have an oral delivery technology at RMIT for protein and peptide drugs, which will allow antimicrobial peptides to be administered orally.

We are currently looking at Priscilicidin as a candidate for this test.”

“Rational design of potent ultrashort antimicrobial peptides with programmable assembly into nanostructured hydrogels” is published in Frontiers in Chemistry (DOI: 10.3389/fchem.2022.1009468).

This research was led by RMIT University in collaboration with CSIRO and Aikenhead Centre for Medical Discovery.

Co-authors are Priscila Cardoso, Samuel Appiah Danso, Andrew Hung, Chaitali Dekiwadia, Nimish Pradhan, Jamie Strachan, Brody McDonald, Kate Firipis, Jacinta F. White, Arturo Aburto-Medina, Charlotte E. Conn and Céline Valéry.



DOI

10.3389/fchem.2022.1009468

Method of Research

Experimental study

Subject of Research

Cells

Article Title

Rational design of potent ultrashort antimicrobial peptides with programmable assembly into nanostructured hydrogels

Article Publication Date

13-Jan-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Auditory Change Processing Markers Unusual in Autism

October 23, 2025

Innovative Center Pioneers Brighter Future for Trauma Survivors

October 23, 2025

Exploring Vicarious Trauma in Hospice Nurses

October 23, 2025

Assessing Muscularity Overvaluation and Eating Disorder Risks

October 23, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1277 shares
    Share 510 Tweet 319
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    308 shares
    Share 123 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    167 shares
    Share 67 Tweet 42
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    132 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Auditory Change Processing Markers Unusual in Autism

Innovative Center Pioneers Brighter Future for Trauma Survivors

Exploring Vicarious Trauma in Hospice Nurses

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.